Clinical Trial Update: Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dasiglucagon for postprandial hypoglycemia after Roux-en-Y gastric bypass has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postprandial Hypoglycemia

Drugs mentioned

• dasiglucagon (dasiglucagon)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Hyperinsulinemic Hypoglycemia, Postprandial Hypoglycemia | Phase 2 | Status: COMPLETED